Integrum AB (FRA:6Y1) Stock Based Compensation: €0.00 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6Y1 Integrum AB FRA:6Y1
53 GF Score
Price €0.69
GF Value €1.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Stock Based Compensation?

Integrum AB FRA:6Y1 +0.44% 53 Stock Based Compensation is €0.00 Mil as of Apr. 2026. GuruFocus rates FRA:6Y1 with a GF Score™ of 53/100 and a GF Value™ of €1.54 (Possible Value Trap). The stock has 4 warning signs investors should review.

Integrum AB's Stock Based Compensation for the three months ended in Apr. 2026 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Apr. 2026 was €0.00 Mil.

Integrum AB Stock Based Compensation Related Terms

Integrum AB Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Integrum AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Stock Based Compensation Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:6Y1
53GF Score
Integrum AB FRA:6Y1
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Integrum AB (FRA:6Y1) has a Stock Based Compensation of €0.00 Mil as of Apr. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Integrum AB and its competitors.
Is Integrum AB's Stock Based Compensation too high?
Integrum AB's current Stock Based Compensation is €0.00 Mil. Overall, Integrum AB has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Stock Based Compensation compare to ABT and SYK?
Integrum AB's Stock Based Compensation of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Integrum AB and its competitors. Integrum AB's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (FRA:6Y1) is currently considered Possible Value Trap. The stock's GF Value™ is €1.54, compared to a current price of €0.69 — trading 55.1% below its estimated fair value. The current Stock Based Compensation is €0.00 Mil. Integrum AB's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Integrum AB (FRA:6Y1), the current Stock Based Compensation is €0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (FRA:6Y1) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of €0.69 is trading 55.1% below its estimated GF Value™ of €1.54. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for FRA:6Y1:

  • Stock Based Compensation: €0.00 Mil
  • GF Value™: €1.54 vs. price of €0.69 (55.1% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the FRA:6Y1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrum AB Business Description

Other Exchanges INTEG B:Sweden
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
53GF Score

Get the complete analysis for FRA:6Y1

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.69
Price
€1.54
GF Value